CMS Entry id: 2709 | Channel: Blog landing page | Template: blog/index

Login
Facebook YouTube Twitter Linkedin
Facebook YouTube Twitter Linkedin

Blog

Assessments of ADAS-Cog administration quality are comparable across expert and non-expert reviewers

This poster was presented at the ISCTM Annual Scientific Meeting in February 2023.

New Commercial Partnership and Further Scientific Validation for NeuroVocalix

Cambridge Cognition is pleased to announce the second commercial partnership with a leading pharmaceutical company, for its NeuroVocalixTM platform. NeuroVocalixTM is a unique voice biomarker technology and the product was launched last year and recently presented ground-breaking demonstrable evidence of the potential at a major global Alzheimer’s conference.  

NeuroVocalix platform ready for clinical trials

NeuroVocalix enables novel voice-based cognitive assessments to be delivered directly to patients through mobile and tele-health platforms, helping to improve outcomes in clinical trials, aid clinical decision-making and play an important role in the management of long-term conditions such as chronic pain.

web-based testing, wearables, voice, virtual clinical trials, technology, swm, subjective measures, stigma, social cognition, smartphones, sleep, schizophrenia research, schizophrenia, safety, rvp, rti, research funding, research, remote testing, regulations, recruitment, rare disease, prodromal, pro-cognitive, prm, press release, presenteeism, precision psychiatry, pre-clinical, poster, personalised medicine, patient-centric, patient recruitment, parkinson's disease, pal, paired associates learning, ots, occupational health, normative data, neuroscience, near-patient testing, multiple sclerosis, mts, ms, modelling, mental wellbeing, mdd, mci, major depression, machine learning, life at cambridge cognition, high-frequency testing, healthcare, grant, funding, fatigue, ert, epidemiology, ebt, early career researchers, early alzheimer's disease, drug development, dms, digital tools, digital health, depression, dementia, covid-19, cognitive testing, cognitive science, cognitive safety, cognitive impairment, cognitive function, cognitive dysfunction, cognitive deficits, cognitive biomarkers, cognitive assessment, cognition kit, cognition, cns summit, clinical trials, clinical trial, cias, chronic illness, chronic health conditions, cgt, cantab testimonial, cantab research grant, cantab, cambridge cognition careers, cambridge cognition, brain health, biomarkers, automatic speech recognition, autism, attention, asr, alzheimer's disease, academic, absenteeism,